Skip to main content

Pfizer to cut 800 scientists

Pfizer will eliminate 5 to 8 percent of its global research staff this year, totaling about 800 people, according to a spokesperson for the company. Pfizer began one-on-one conversations today with colleagues getting the boot, with the majority of lay-offs happening in the next several months, company spokesperson Christopher Loder told The Scientist. Loder declined to provide details on which research divisions will be hit the hardest but emphasized that Pfizer is honing its research staff to

Written byAndrea Gawrylewski
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Pfizer will eliminate 5 to 8 percent of its global research staff this year, totaling about 800 people, according to a spokesperson for the company. Pfizer began one-on-one conversations today with colleagues getting the boot, with the majority of lay-offs happening in the next several months, company spokesperson Christopher Loder told The Scientist. Loder declined to provide details on which research divisions will be hit the hardest but emphasized that Pfizer is honing its research staff to six major areas of disease research: oncology, Alzheimer's, schizophrenia, pain, diabetes, and inflammation. "We do not make these decisions lightly," he said. "We are aware that this decision will affect a of number people, colleagues, and their family. We are committed to supporting our colleagues through this transition." Pfizer suffered last year from slumping sales of its blockbuster cholesterol drug Lipitor, thanks to the availability of a generic version. "This is probably not the end" of layoffs at Pfizer, linkurl:Erik Gordon,;https://www.bus.umich.edu/FacultyBios/FacultyBio.asp?id=000191546 a professor at the University of Michigan Business School and biopharmaceutical analyst, told linkurl:The New York Times.;https://www.nytimes.com/2009/01/14/business/14pfizer.html?_r=2&hp The pharmaceutical giant is not the only one cutting jobs and reorganizing priorities. Last October Merck announced that it would slash 7,200 jobs by 2011. In addition, Merck and Novartis both have recently revamped their research and development tactics.
**__Related stories:__***linkurl:Merck to cut jobs;https://www.the-scientist.com/blog/display/55103/
[22nd October 2008]*linkurl:New directions for drug discovery;https://www.the-scientist.com/blog/display/55274/
[9th December 2008]*linkurl:Pfizer embraces stem cells;https://www.the-scientist.com/blog/display/55051/
[24th September 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays